前列腺多参数磁共振成像与前列腺癌初次治疗后肿瘤学结局的关联:系统综述与荟萃分析
该系统综述与荟萃分析评估了治疗前多参数磁共振成像(mpMRI)与前列腺癌(PCa)初次治疗后肿瘤学结局的关系。共纳入6项研究,多数研究显示PI-RADS评分是根治性前列腺切除术后生化复发(BCR)的独立预测因子,而mpMRI肿瘤体积与BCR无显著关联。数据异质性较大,关于疾病进展和PCa特异性死亡的数据有限。
要点
- PI-RADS评分是根治性前列腺切除术后生化复发的独立预测因子。
- mpMRI肿瘤体积与根治性前列腺切除术后生化复发无显著关联。
- PI-RADS评分信息应纳入未来风险模型以识别不良结局高危患者。
核心结论
- PI-RADS评分可提供根治性前列腺切除术后癌症复发或进展的未来可能性信息。
- 该信息应被考虑用于识别不良结局风险较高的男性。
研究设计与样本
- 系统综述与荟萃分析,检索MEDLINE/PubMed、EMBASE、Scopus和Cochrane Library CENTRAL数据库。
- 共纳入6项评估mpMRI与前列腺癌初次治疗后肿瘤学结局关系的研究。
- 综述方案在PROSPERO注册(CRD42020209899)。
主要发现
- 多数纳入研究显示PI-RADS评分是根治性前列腺切除术后生化复发的独立预测因子。
- mpMRI肿瘤体积与根治性前列腺切除术后生化复发无显著关联。
- 关于疾病进展和前列腺癌特异性死亡的数据有限。
- 研究间异质性较大。
临床怎么用
- 可将PI-RADS评分纳入风险模型以识别根治性前列腺切除术后不良结局高危患者。
局限性
- 该领域可靠证据仍有限。
- 研究间异质性较大。
- 关于疾病进展和前列腺癌特异性死亡的数据有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: The diagnostic accuracy of multiparametric magnetic resonance imaging (mpMRI) for prostate cancer (PCa) diagnosis has been extensively explored. Little is known about the prognostic value of mpMRI suspicion scores and other quantitative mpMRI information. OBJECTIVE: To systematically review the current literature assessing the relationship between pretreatment mpMRI and oncological outcomes after primary treatment for PCa to assess the role of mpMRI as a prognostic tool. EVIDENCE ACQUISITION: A computerized bibliographic search of MEDLINE/PubMed, EMBASE, Scopus, and the Cochrane Library CENTRAL databases was performed for all studies assessing the relationship between mpMRI and oncological outcomes after primary treatment for PCa. The review protocol is registered in the PROSPERO database (CRD42020209899). EVIDENCE SYNTHESIS: A total of six studies were included. Reliable evidence is still limited in this field. The Prostate Imaging-Reporting and Data System (PI-RADS) score was an independent predictor of biochemical recurrence (BCR) after radical prostatectomy (RP) in the majority of the studies included. The tumor volume at mpMRI was not significantly associated with BCR after RP for PCa. Data on disease progression and PCa-specific mortality are limited. Heterogeneity among the studies was substantial. CONCLUSIONS: The review shows that PI-RADS scores provide information on the future likelihood of cancer recurrence or progression, at least for men undergoing RP. We are of the view that this information should be taken into account to identify men at higher risk of unfavorable outcomes. PATIENT SUMMARY: A higher Prostate Imaging-Reporting and Data System score for magnetic resonance imaging of the prostate seems to be positively associated with oncological failure in prostate cancer and should be incorporated into future risk models.
引用
- Stabile A, Mazzone E, Cirulli GO, et al. Association Between Multiparametric Magnetic Resonance Imaging of the Prostate and Oncological Outcomes after Primary Treatment for Prostate Cancer: A Systematic Review and Meta-analysis. Eur Urol Oncol. 2020. PMID: 33384275. doi:10.1016/j.euo.2020.11.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。